Answers are grounded in this paper and cite their sources.
Hypothesis-generating from Level 5 evidence; leaves open clinical role of platelet inhibitors pending randomized trials.
* Presented at the National Conference on Thrombosis and Hemostasis, under the auspices of the Council on Thrombosis of the American Heart Association, Dallas, Texas, November, 1974. ** Please address all correspondence to Dr. J. Hirsh, Department of Pathology, McMaster University Medical Center, Hamilton, Ontario, Canada.
No takes yet. Share an insight, caveat, or question.
Hirsh et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: